A NEW ERA FOR HEALTHCARE: $350 MILLION REVAMP FOR CANTERBURY HOSPITAL
Canterbury Hospital is set for a historic $350 million redevelopment, marking its first major upgrade in nearly three decades. ... Read More
CHILDHOOD MYOPIA ON THE RISE: HOW PANDEMIC LOCKDOWNS IMPACTED CHILDREN’S VISION
A recent study has revealed a concerning rise in childhood myopia (nearsightedness), with cases increasing by 42% among preschool children following COVID-19 lockdowns. ... Read More
BREAKTHROUGH DISCOVERY: AI-POWERED PREGNANCY ANALYSIS REVEALS HIDDEN RISKS FOR ADVERSE OUTCOMES
In a groundbreaking advancement, researchers have harnessed the power of artificial intelligence (AI) to uncover previously unidentified risk factor combinations that contribute to severe pregnancy complications. ... Read More
BREAKING NEWS: FDA APPROVES SUZETRIGINE (JOURNAVX) – A GAME-CHANGING NON-OPIOID PAIN RELIEF MEDICATION
The U.S. Food and Drug Administration (FDA) has officially approved Suzetrigine (Journavx)—a groundbreaking, non-opioid oral medication designed to manage acute pain in adults. ... Read More